N, N'-substituted-1,3-diamino-2-hydroxypr opane derivatives

Details for Australian Patent Application No. 2002359376 (hide)

Owner Pharmacia and Upjohn Company LLC Elan Pharmaceuticals, Inc.

Inventors Hom, Roy; Freskos, John; Fang, Larry; Mickelson, John; Samala, Lakshman; Maillard, Michel; John, Varghese; Jagodzinska, Barbara; Sealy, Jennifer; Beck, James P; Tenbrink, Ruth; Gailunas, Andrea

Agent Pizzeys

Pub. Number AU-B-2002359376

PCT Number PCT/US02/36072

PCT Pub. Number WO2003/040096

Priority 60/345,635 03.01.02 US; 60/337,122 08.11.01 US; 60/344,086 28.12.01 US

Filing date 8 November 2002

Wipo publication date 19 May 2003

Acceptance publication date 10 January 2008

International Classifications

C07D 295/16 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/164 (2006.01) - of a carboxylic acid with an aminoalcohol, e.g. ceramides

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/27 (2006.01)

A61K 31/336 (2006.01) - having three-membered rings, e.g. oxirane, fumagillin

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/36 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/39 (2006.01) - having oxygen atoms in the same ring

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/437 (2006.01)

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/345,635 03.01.02 US; 60/337,122 08.11.01 US; 60/344,086 28.12.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002359376

10 January 2008 Application Accepted

  Published as AU-B-2002359376

24 January 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Pharmacia and Upjohn Company LLC, Application No. 2002359376 Under INID (51) Delete all IPC marks between A61K 31/164 (2006.01) and CO7C 235/20 (2006.01).

8 May 2008 Standard Patent Sealed

2 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002359377-COMPUTERIZED METHOD FOR DETERMINATION OF THE LIKELIHOOD OF MALIGNANCY FOR PULMONARY NODULES ON LOW-DOSE CT

2002359375-ENABLING SECURE COMMUNICATION IN A CLUSTERED OR DISTRIBUTED ARCHITECTURE